Paper36969867
Research progress of Astaxanthin nano-based drug delivery system: Applications, prospects and challenges?
Chen S and 3 others. Front Pharmacol, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Research progress of Astaxanthin nano-based drug delivery system: Applications, prospects and challenges? Papers, record 36969867. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969867
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Research progress of Astaxanthin nano-based drug delivery system: Applications, prospects and challenges?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35056816 | Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications. | Molecules | 2022 | https://conductscience.org/library/papers/35056816 | PubMed |
| 2 | 31470537 | Sublingual Delivery of Astaxanthin through a Novel Ascorbyl Palmitate-Based Nanoemulsion: Preliminary Data. | Mar Drugs | 2019 | https://conductscience.org/library/papers/31470537 | PubMed |
| 3 | 23590613 | Physico-chemical stability of astaxanthin nanodispersions prepared with polysaccharides as stabilizing agents. | Int J Food Sci Nutr | 2013 | https://conductscience.org/library/papers/23590613 | PubMed |
| 4 | 30172200 | Astaxanthin-alpha tocopherol nanoemulsion formulation by emulsification methods: Investigation on anticancer, wound healing, and antibacterial effects. | Colloids Surf B Biointerfaces | 2018 | https://conductscience.org/library/papers/30172200 | PubMed |
| 5 | 33155666 | Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). | Int J Mol Med | 2021 | https://conductscience.org/library/papers/33155666 | PubMed |
| 6 | 34636497 | Multi-Mechanistic Antidiabetic Potential of Astaxanthin: An Update on Preclinical and Clinical Evidence. | Mol Nutr Food Res | 2021 | https://conductscience.org/library/papers/34636497 | PubMed |
| 7 | 31251469 | Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models. | IUBMB Life | 2019 | https://conductscience.org/library/papers/31251469 | PubMed |
| 8 | 27428953 | Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute Hepatotoxicity. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27428953 | PubMed |
| 9 | 33761600 | Nrf2 a molecular therapeutic target for Astaxanthin. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/33761600 | PubMed |
| 10 | 32784629 | Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer. | Mar Drugs | 2020 | https://conductscience.org/library/papers/32784629 | PubMed |
| 11 | 35406135 | Astaxanthin Bioactivity Is Determined by Stereoisomer Composition and Extraction Method. | Nutrients | 2022 | https://conductscience.org/library/papers/35406135 | PubMed |
| 12 | 32937179 | Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy. | Eur J Pharm Biopharm | 2020 | https://conductscience.org/library/papers/32937179 | PubMed |
| 13 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 14 | 34286807 | Preparation and characterization of glycosylated protein nanoparticles for astaxanthin mitochondria targeting delivery. | Food Funct | 2021 | https://conductscience.org/library/papers/34286807 | PubMed |
| 15 | 31619957 | Receptor-Mediated Delivery of Astaxanthin-Loaded Nanoparticles to Neurons: An Enhanced Potential for Subarachnoid Hemorrhage Treatment. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31619957 | PubMed |
| 16 | 34677433 | Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control. | Mar Drugs | 2021 | https://conductscience.org/library/papers/34677433 | PubMed |
| 17 | 35423427 | Cytotoxicity of targeted PLGA nanoparticles: a systematic review. | RSC Adv | 2021 | https://conductscience.org/library/papers/35423427 | PubMed |
| 18 | 34126176 | Preparation of astaxanthin micelles self-assembled by a mechanochemical method from hydroxypropyl β-cyclodextrin and glyceryl monostearate with enhanced antioxidant activity. | Int J Pharm | 2021 | https://conductscience.org/library/papers/34126176 | PubMed |
| 19 | 12727382 | Haematococcus astaxanthin: applications for human health and nutrition. | Trends Biotechnol | 2003 | https://conductscience.org/library/papers/12727382 | PubMed |
| 20 | 30380797 | Nanoliposomes as Vehicles for Astaxanthin: Characterization, In Vitro Release Evaluation and Structure. | Molecules | 2018 | https://conductscience.org/library/papers/30380797 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42382501 | Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42382501 | PubMed |
| 42310631 | Hepatorenal protective and antitumor effects of astaxanthin-loaded chitosan nanoparticles against ehrlich ascites carcinoma in mice through antioxidant, anti-inflammatory, and apoptotic pathway modulation. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42310631 | PubMed |
| 42198217 | Astaxanthin Delivery Across Administration Routes: Recent Advances to Improve Stability and Bioavailability. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198217 | PubMed |
| 41978098 | Synergistic Effects of a Pro-Inflammatory-High-Fat Composite Dietary Pattern on Gut-Liver Injury and the Therapeutic Potential of Haematococcus pluvialis-Derived Astaxanthin. | Nutrients | 2026 | https://conductscience.org/library/papers/41978098 | PubMed |
| 41599661 | Innovations in the Delivery of Bioactive Compounds for Cancer Prevention and Therapy: Advances, Challenges, and Future Perspectives. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599661 | PubMed |
| 41404045 | Biological function of astaxanthin and its application in aquatic animal feeding. | Food Chem X | 2025 | https://conductscience.org/library/papers/41404045 | PubMed |
| 41155474 | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155474 | PubMed |
| 39698514 | Intranasal delivery of macrophage cell membrane cloaked biomimetic drug-nanoparticle system attenuates acute lung injury. | J Tissue Eng | 2024 | https://conductscience.org/library/papers/39698514 | PubMed |
| 39475763 | The senomorphic impact of astaxanthin on irradiated rat spleen: STING, TLR4 and mTOR contributed pathway. | Int J Immunopathol Pharmacol | 2024 | https://conductscience.org/library/papers/39475763 | PubMed |
| 39061947 | Recent Advances in Astaxanthin as an Antioxidant in Food Applications. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39061947 | PubMed |
| 38794332 | A Review of Recent Developments in Biopolymer Nano-Based Drug Delivery Systems with Antioxidative Properties: Insights into the Last Five Years. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38794332 | PubMed |
| 38132951 | The Clinical Promise of Microalgae in Rheumatoid Arthritis: From Natural Compounds to Recombinant Therapeutics. | Mar Drugs | 2023 | https://conductscience.org/library/papers/38132951 | PubMed |
| 37998337 | Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies? | Cells | 2023 | https://conductscience.org/library/papers/37998337 | PubMed |
| 37888465 | Extraction and Purification of Highly Active Astaxanthin from Corynebacterium glutamicum Fermentation Broth. | Mar Drugs | 2023 | https://conductscience.org/library/papers/37888465 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969867
GET https://conductscience.org/api/papers/v1/36969867/references?page=2